Clinical trials
Pancreatic Neoplasms trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 5 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 9 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Recruiting | 14 |
| Unknown status | 10 |
| Terminated | 9 |
| Active, not recruiting | 6 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Herlev Hospital | 9 |
| Inna Chen, MD | 6 |
| Rigshospitalet, Denmark | 5 |
| Michael Bau Mortensen | 3 |
| Odense University Hospital | 3 |
| University of Copenhagen | 3 |
| Aalborg University Hospital | 2 |
| AstraZeneca | 2 |
| Incyte Corporation | 2 |
| Jens Rikardt Andersen | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 69 |
| Neoplasms | 11 |
| Esophageal Neoplasms | 9 |
| Stomach Neoplasms | 8 |
| Biliary Tract Neoplasms | 4 |
| Breast Neoplasms | 4 |
| Colorectal Neoplasms | 4 |
| Liver Neoplasms | 4 |
| Lung Neoplasms | 4 |
| Neoplasm Metastasis | 4 |
Trials
Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.